Vaccine Partnering Terms and Agreements

Pages » 1508
Published By » Current Partnering
Price » $2995
In stock
View Report Details
Description

The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines  The report provides a detailed understanding and...


Bioinformatics Partnering Terms and Agreements
The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe bioinformatics partnering deals and agreements entered intby the worlds leading healthcare companies. Trends in bioinformatics partnering deals Deal terms analysis
Published Date: Sep 2013
Price: $2995
Vaccine Partnering Terms and Agreements
The Vaccine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the vaccine partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in vaccine and adjuvant partnering deals Deal terms an
Published Date: Jan 2014
Price: $2995
Orphan Drugs Partnering Terms and Agreements
The Orphan Drugs Partnering Terms and Agreements report provides an understanding and access to the orphan drugs partnering deals and agreements entered into by the worlds leading healthcare companies.   Trends in orphan drugs partnering deals Disclosed headlines, upfronts, milestone
Published Date: Aug 2013
Price: $1795
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
The Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This rep
Published Date: Jul 2011
Price: $2995
Pharmacogenomic Partnering Terms and Agreements
The Pharmacogenomic Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the pharmacogenomic partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analy
Published Date: Apr 2011
Price: $2695
Biomarker Partnering Terms and Agreements
The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering a
Published Date: Sep 2013
Price: $2795
Companion Diagnostics Partnering Terms and Agreements
The Companion Diagnostics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe companion diagnostics partnering deals and agreements entered intby the worlds leading healthcare companies.   The report provides a detailed underst
Published Date: Oct 2013
Price: $1795
Partnering Terms and Agreements in Diagnostics, 2nd edition
The Partnering Terms and Agreements in Diagnostics report provides comprehensive understanding and unprecedented access to the diagnostic partnering agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and
Published Date: Nov 2010
Price: $2695
Discovery Stage Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Discovery Stage Partnering Terms and Agreements in Pharma and Biotech report detailed understanding and analysis of how and why companies enter discovery stage licensing/business development and other forms of partnering arrangement. The report provides a detailed understanding and anal
Published Date: Jun 2010
Price: $2695
Option & Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics
The Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. The report provide
Published Date: Sep 2013
Price: $2795

 


 

Related News

Miners fall on Chinese concerns while Pharmaceutical deal activities raise FTSE
After the Easter break, the number of deals in the pharmaceutical sector have aggravated the UK market. After reports of a $100bn takeoverapproach from Pfizer, a 7% rise is seen in AstraZeneca shares.Also, a 4% rise in GlaxoSmithkline (the complicated asset swap with Novartis) has helped lift the FTSE 100. Shire is the rumored candidate that is sharply budding up in the market adding 125p or 4% to £30.50. However, on the contraryBabcock International has dropped 9p to £12.07.
Date: Apr 22

Election of Stable Government Could Push USD 30 billion M&A Deals in India
Market watchers opine that the Indian market for mergers and acquisitions is poised to witness increase momentum following the general elections that are currently underway in the world’s largest democracy. Analysts believe that post the general elections, the total value of M&A deals could well be over USD 30 billion, if a stable government is elected at the center in the current Lok Sabha polls. Experts predict the pace of inbound deals to be much higher following the elections
Date: Apr 15

Beshear Promotes a Group to Boost Auto Industry in Kentucky
Kentucky seeks to be closely identified with the auto industry same as Detroit, says Gov. Steve Beshear when he launched the Kentucky Automotive Industry Association on Monday.  Beshear said at a Capitol news conference that the group aims to be the voice and unified icon for an industry sector that is important to our state’s growing economic health and growth. He added that the association is focusing on branding, leadership, and advocacy, and similarly, 12 other states have such
Date: Apr 08

Alibaba Founder Invests USD 531.78 in Financial Software Enterprise
Chinese billionaire Jack Ma, who is credited for founding the world’s largest e-commerce firm Alibaba Group Holding, is investing USD 531.78 million to gain a controlling share in Hundsun Technologies Inc, a financial software firm. Hundsun Group-that controls a 20.6% stake in Hundsun Technologies-would sell its entire stake in the latter to Zhejiang Finance Credit Network Technology Co, a company in which Ma owns a 99% stake.  This deal will render Ma a controlling stake in Hun
Date: Apr 03

Rising Air Pollution Spur Chinese Citizens to Import Fresh Mountain Air in Vacuum Packed Bags
Air pollution levels in China have mounted to levels such high that even a spurt of fresh air these days seems like a matter of past. The situation is clearly visible from the most recent attack of thick smog in Zhengzhou (the city is still gulped by it), the capital of Henan province, one of China’s 10 most polluted places.  Citing the ever increasing levels of air pollution, many people have opted to move out of polluted cities in China. But life is not easy for the ones who st
Date: Apr 02

8.2 Magnitude Earthquake in Chile Triggers Tsunami Warnings
A high magnitude earthquake that measured 8.2 richters struck off the coasts of Chile this Tuesday night. The earthquake caused landslides and triggered a small Tsunami on Chile’s coastline. The centre of the earthquake was about 60 miles northwest of the town Iquiqe.   The hustle created by the earthquake also resulted in fleeing of more than 300 prisoners from a jail. This has led the military to take control over the town to prevent any mishaps. Emergency officials have reported
Date: Apr 02

Apple Files Petition for Patent of Innovative Technology That Makes Texting While Walking Safer
You can now let go of your worries of getting bumped on a pole or getting stumped while walking just because your eyes are glued to your smartphone’s screen and you are too busy concentrating at texting while walking.  US technology giant Apple is soon to introduce a technology (it has already filed a petition for its patent) that does not even require you to pull your head out of your phone and look around - a live video feed of anything that is in the front of you, or essentially
Date: Apr 01

U.S. FDAs Stamp of Approval for Xolair Drug Developed by Novartis and Genentech
The United States Food and Drug Administration (FDA) has stamped its mark of approval for Xolair (omalizumab), a drug developed by Novartis and Genentech. Xolair has been developed for treating a debilitating skin condition that is known as chronic idiopathic urticaria (CIU). The occurrence of this condition is unpredictable, and outside of the United States this disease is also known by another name--chronic spontaneous urticaria (CSU). The company was reported as stating that the drug&rsquo
Date: Mar 28

Telco Industry Demands More Deregulation
AMTA, Communications Alliance supports the ‘red tape’ repeal dealings with the federal government  Since, the federal government reduced the regulations pertaining to the telco and broader communications industries, The Communications Alliance and the Australian Mobile Telecommunications Association (AMTA) have shown a positive reaction to the government’s decision.  Malcolm Turnbull, Communications minister and parliamentary secretary Paul Fletcher state that t
Date: Mar 20

New Porous Materials Demand in the Industry Chemicals and Materials
The industry has come up with new class of making porous materials that significantly controls a wide range of applications and greater manufacturing applications to handle long term industry standard applications.  This discovery was conducted by a team of University of Connecticut chemists that found out the creation of over 60 new families in the field of chemicals and materials. The study was conducted with the potential for many more chemicals and materials. The key purpose in th
Date: Mar 19

Upcoming Reports

DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019
Vaccines have been in use since decades to provide immunological responses against diseases. A conventional vaccine is a biological preparation of weakened or attenuated, killed forms of a microbe or one of its cellular components, while a DNA vaccine is composed of genetically engineered DNA. Whe
Published By: Transparency Market Research
Price: $4795
Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Meningococcal vaccines are used against Nisseria meningitidis, a gram negative bacterium that causes various types of meningococcal diseases such as meningitis, meningococcemia and septicemia. World Healthcare Organization (WHO) reports suggest 12 clinically significant serogroups of Neisseria men
Published By: Transparency Market Research
Price: $4795
HPV Therapeutic Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers
Published By: Transparency Market Research
Price: $4795